HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+7.24%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$984M
AUM Growth
+$984M
(+8.3%)
Cap. Flow
+$13.1M
Cap. Flow
% of AUM
1.34%
Top 10 Holdings %
Top 10 Hldgs %
54.55%
Holding
135
New
7
Increased
20
Reduced
9
Closed
8
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$7.02M |
| 2 |
General Mills
GIS
|
$4.27M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
$3.52M |
| 4 |
Johnson & Johnson
JNJ
|
$3.4M |
| 5 |
Kraft Heinz
KHC
|
$2.8M |
Top Sells
| 1 |
IBM
IBM
|
$12.3M |
| 2 |
Amgen
AMGN
|
$2.9M |
| 3 |
Gilead Sciences
GILD
|
$2.69M |
| 4 |
Biogen
BIIB
|
$2.01M |
| 5 |
CELG
Celgene Corp
CELG
|
$1.63M |
Sector Composition
| 1 | Financials | 35.78% |
| 2 | Healthcare | 22.27% |
| 3 | Industrials | 11.22% |
| 4 | Technology | 7.01% |
| 5 | Consumer Staples | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
NOV
NOV
$4.82B
| $9.7M | 0.99% |
225,100
| – | – |
|
|
BBL
27
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $9.26M | 0.94% |
210,530
| – | – |
|
28
Colgate-Palmolive
CL
$67.7B
| $9.01M | 0.92% |
134,590
+18,890
| +16% | +$1.26M |
|
29
AB InBev
BUD
$116B
| $8.49M | 0.86% |
96,950
+27,950
| +41% | +$2.45M |
|
30
Cisco
CSCO
$268B
| $7.69M | 0.78% |
158,000
| – | – |
|
|
31
Amgen
AMGN
$153B
| $7.08M | 0.72% |
34,130
-14,000
| -29% | -$2.9M |
|
32
Vanguard S&P 500 ETF
VOO
$724B
| $6.86M | 0.7% |
25,690
| – | – |
|
|
33
Gilead Sciences
GILD
$140B
| $6.54M | 0.66% |
84,650
-34,800
| -29% | -$2.69M |
|
34
Sanofi
SNY
$122B
| $6.12M | 0.62% |
137,040
| – | – |
|
35
US Bancorp
USB
$75.5B
| $6.06M | 0.62% |
114,700
+1,800
| +2% | +$95.1K |
|
36
Becton Dickinson
BDX
$54.3B
| $5.95M | 0.61% |
22,800
| – | – |
|
37
GE Aerospace
GE
$293B
| $5.89M | 0.6% |
521,600
+15,300
| +3% | +$173K |
|
38
Vanguard Consumer Staples ETF
VDC
$7.61B
| $5.69M | 0.58% |
40,600
+14,180
| +54% | +$1.99M |
|
|
39
Biogen
BIIB
$20.8B
| $5.04M | 0.51% |
14,260
-5,680
| -28% | -$2.01M |
|
40
Medtronic
MDT
$118B
| $4.99M | 0.51% |
50,700
| – | – |
|
|
RDS.B
41
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $4.75M | 0.48% |
67,000
| – | – |
|
42
Alphabet (Google) Class C
GOOG
$2.79T
| $4.66M | 0.47% |
3,900
| – | – |
|
|
SGYP
43
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $4.25M | 0.43% |
2,500,000
+200,000
| +9% | +$340K |
|
|
CELG
44
DELISTED
Celgene Corp
CELG
| $4.13M | 0.42% |
46,170
-18,200
| -28% | -$1.63M |
|
45
Bristol-Myers Squibb
BMY
$96.7B
| $3.85M | 0.39% |
62,080
| – | – |
|
46
iShares Biotechnology ETF
IBB
$5.68B
| $3.16M | 0.32% |
25,900
| – | – |
|
47
Altria Group
MO
$112B
| $2.92M | 0.3% |
48,450
+15,950
| +49% | +$962K |
|
|
SRCL
48
DELISTED
Stericycle Inc
SRCL
| $2.79M | 0.28% |
47,600
| – | – |
|
|
AKTX
49
Akari Therapeutics
AKTX
$21.4M
| $2.56M | 0.26% |
1,000,000
+156,151
| +19% | +$400K |
|
50
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$2.31B
| $2.45M | 0.25% |
96,500
+35,800
| +59% | +$907K |
|